Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia: Guidelines from the Infectious Disease Society of America. Clin Infect Dis. 2000; 31:347–382.
DOI: https://doi.org/10.1086/313954
Niederman M S, Bass J B Jr, Campbell G D, Fein A M, Grossman R F, Mandell L A, et al. American Thoracic Society guidelines for the initial management of adults with communityacquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: 1418-26.
DOI: https://doi.org/10.1164/ajrccm/148.5.1418
Woodhead M. Community-acquired Pneumonia Guidelines. An international comparison. A view from Europe. Chest 1998; 113: S183S-S187.
DOI: https://doi.org/10.1378/chest.113.3_Supplement.183S
Calmaggi A, Clara L, González Arzac M, López Furst M J, Levy Hara G. Guías para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en adultos. Infect Microbiol Clin 2000
Bantar, C, Bavestrello, L, Curcio, D, Jasovich A, Absi R, Bagnulo H, et al. Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur). J Chemother 2002; 14 (Suppl 4): 1-22.
DOI: https://doi.org/10.1080/1120009X.2002.11782352
Mandell L, Wunderink R, Anzueto A, Bartlett J G, Campbell G D, Dean N C, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007; 44: 27-72.
DOI: https://doi.org/10.1086/511159
Diehr P, Wood RW, Bushyhead J, et al. Prediction of pneumonia in outpatients with acute cough—a statistical approach. J Chronic Dis 1984; 37:215–25.
DOI: https://doi.org/10.1016/0021-9681(84)90149-8
Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet 1988; 1:873–5.
DOI: https://doi.org/10.1016/S0140-6736(88)91613-3
Heckerling PS, Tape TG, Wigton RS, et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med. 1990; 113:664-670.
DOI: https://doi.org/10.7326/0003-4819-113-9-664
Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157:1453–9.
DOI: https://doi.org/10.1001/archinte.157.13.1453
Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278:1440–5.
DOI: https://doi.org/10.1001/jama.278.17.1440
Saldías F., Méndez J., Ramírez D, Díaz O. Valor predictivo de la historia clínica y el examen físico en el diagnóstico de la neumonía del adulto adquirida en la comunidad. Revisión de la literatura. Rev Med Chile 2007; 135: 517-528.
DOI: https://doi.org/10.4067/S0034-98872007000400016
Levy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 93: 43-8.
DOI: https://doi.org/10.1378/chest.93.1.43
Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, et al. Severe Community-acquired pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clin Infect Dis 2009; 48: 377-85.
Valencia M, Badia J R, Cavalcanti M, Ferrer M, index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007; 132: 515-22.
DOI: https://doi.org/10.1378/chest.07-0306
Renaud B, Coma E, Labarere J, Hayon J, Roy P M, Boureaux H, et al. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 2007; 44: 41-9.
DOI: https://doi.org/10.1086/509331
Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007; 62:253–9.
DOI: https://doi.org/10.1136/thx.2006.067371
Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006; 35: 286-91.
DOI: https://doi.org/10.1093/ageing/afj081
Bantar C et al. Neumonía aguda adquirida en la comunidad en adultos: Actualización de los lineamientos para el tratamiento antimicrobiano inicial basado en la evidencia local del Grupo de Trabajo de Sudamérica (ConsenSur II) Rev Chil Infect 2010; 27 (Supl 1): 9-38.
DOI: https://doi.org/10.4067/S0716-10182010000400002
Van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broads pectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 2005; 60:672–8.
Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59:960–5.
DOI: https://doi.org/10.1136/thx.2003.017756
Mundy LM, Leet TL, Darst K, Schnitzler MA, Dunagan WC. Early mobilization of patients hospitalized with community-acquired pneumonia. Chest. 2003; 124 (3):883-889.
DOI: https://doi.org/10.1378/chest.124.3.883
Eliakim-Raz Noa, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev. 2012 Sep 12;9.
DOI: https://doi.org/10.1002/14651858.CD004418.pub4
Lim WS, Baudouin SV, George RC, et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; Vol. 64 (Suppl 3)
DOI: https://doi.org/10.1136/thx.2009.121434
Jasovich A, Soutric J, Morera G, Mastruzzo M, Vesco E, Izaguirre M, et al. Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of communityacquired pneumonia. A clinical trial based on a pharmacodynamic model. J Chemother 2002; 14: 591-6.
DOI: https://doi.org/10.1179/joc.2002.14.6.591
Aubier M, Verster R, Regamey C, Geslin P, Vercken J B. Once-daily sparfl oxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Clin Infect Dis 1998; 26:1312-20.
DOI: https://doi.org/10.1086/516366
O’Doherty B, Dutchman D A, Pettit R,Maroli A. Randomized, double-blind,comparative study of grepafl oxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother 1997; 40 (Suppl A): 73-81.
DOI: https://doi.org/10.1093/jac/40.suppl_1.73
Tremolieres F, de Kock F, Pluck N, Daniel R. Trovafl oxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17: 447-53.
DOI: https://doi.org/10.1007/BF01691581
Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997; 278:32–9.
DOI: https://doi.org/10.1001/jama.1997.03550010046038
Ailani RK, Agastya G, Mukunda BN, et al. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med.1999; 159:266–70.
DOI: https://doi.org/10.1001/archinte.159.3.266
Teh B, Grayson ML, Johnson PD, Charles PG. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect 2012.
DOI: https://doi.org/10.1111/j.1469-0691.2011.03759.x
Choudhury G, Mandal P, Singanayagam A, et al. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia- a propensity-adjusted analysis. Clin Microbiol Infect. 2011; 17:1852–8.
DOI: https://doi.org/10.1111/j.1469-0691.2011.03542.x
Avdic E, Cushinotto LA, Hughes AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012; 54(11):1581–7.
Aliberti S, Blasi F, Zanaboni AM, et al. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J. 2010; 36:128–34.
DOI: https://doi.org/10.1183/09031936.00130909
Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279:1452–7.
Carratala J, Garcia-Vidal C, Ortega L, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia. Arch Intern Med. 2012; 172(12):922–8.
DOI: https://doi.org/10.1001/archinternmed.2012.1690
Menendez T, Torres A, Rodriguez de Castro F, et al. Reaching stability in community- acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004; 39:1783–90.
DOI: https://doi.org/10.1086/426028
Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, et al. Short versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008; 68(13):1841–54.
DOI: https://doi.org/10.2165/00003495-200868130-00004
Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165:1992–2000.
DOI: https://doi.org/10.1001/archinte.165.17.1992
Mills GD, Oehley MR, Arrol B. Effectiveness of b-lactam antibiotics compared with antibiotics active against atypical pathogens in nonsevere community acquired pneumonia: meta-analysis. BMJ 2005; 330:456–60.
DOI: https://doi.org/10.1136/bmj.38334.591586.82
El Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir. Crit. Care Med 2001; 163: 645–51.
DOI: https://doi.org/10.1164/ajrccm.163.3.2005075
Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118:1344–54.
DOI: https://doi.org/10.1378/chest.118.5.1344
Leroy O, Santre C, Beuscart C, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21:24–31.
DOI: https://doi.org/10.1007/BF02425150
Sapira JD. The Art and Science of Bedside Diagnosis. Baltimore, MD: Williams & Wilkins; 1990. 13. Forgacs P. Lung sounds. Br J Dis Chest. 1969; 63(1):1-12.
DOI: https://doi.org/10.1016/S0007-0971(69)80039-2
Marrie T, Lau C, Wheeler S, Wong C J,Feagan B G. Predictors of symptom resolution in patients with community-acquired pneumonia. Clin Infect Dis 2000; 31: 1362-7.
DOI: https://doi.org/10.1086/317495
Metlay J P, Atlas S J, Borowsky L H,Singer D E. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med 1998; 92: 1137-42.
DOI: https://doi.org/10.1016/S0954-6111(98)90408-5
Okimoto N, Yamato K, Kurihara T. Clinical predictors for the detection of community-acquired pneumonia in adults as a guide to ordering chest radiographs. Respirology.2006- 11, 322–324.
DOI: https://doi.org/10.1111/j.1440-1843.2006.00846.x
Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Infectious Diseases 2000; 31:383-421.
DOI: https://doi.org/10.1086/313959
Levy ML, Le Jeune I, Woodhead MA, Macfarlaned JT, Lim WS; British Thoracic Society Community Acquired Pneumonia in Adults Guideline Group. Thorax October 2009. Vol 64 Supplement III.
Woodhead M, Blasi F, Ewig S, Huchon G,Ieven M, Ortqvist A, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80.
Majumdar SR, Eurich DT, Gamble JM, et al. Oxygen saturations less than 92 % are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clin Infect Dis 2011; 52:325-31.
DOI: https://doi.org/10.1093/cid/ciq076
Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, et al. Severe Community-acquired pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clin Infect Dis 2009; 48: 377-85.
DOI: https://doi.org/10.1086/596307
Neill A M, Martín J R, Weir R, Anderson R,Cherevshsky A, Epton M J, et al. Communityacquired pneumonia: aetiology and usefulnesof severity criteria on admission. Thorax 1996; 51: 1010-6.
DOI: https://doi.org/10.1136/thx.51.10.1010
Fine M J, Auble T E, Yealy D M, Hanusa B H, Wiessfeld L A, Singer D E, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
DOI: https://doi.org/10.1056/NEJM199701233360402
Fine M J, Hough L J, Medsger A R, Li Y H, Ricci E M, Singer D E, et al. The hospital admission decision for patients with community-acquired pneumonia: results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157:36-44.
DOI: https://doi.org/10.1001/archinte.157.1.36
Garcia-Vazquez E, Marcos MA, Mensa J, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med 2004; 164:1807–11.
DOI: https://doi.org/10.1001/archinte.164.16.1807
Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123:1142.
DOI: https://doi.org/10.1378/chest.123.4.1142
Waterer GW, Wunderink RG. The influence of the severity of community- acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95:78–82.
DOI: https://doi.org/10.1053/rmed.2000.0977
Low DE, Green K, et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40:1288-97.
DOI: https://doi.org/10.1086/429242
Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2000; 162:154–60.
DOI: https://doi.org/10.1164/ajrccm.162.1.9907023
Van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broads spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomized study. Thorax 2005; 60:672–8.
DOI: https://doi.org/10.1136/thx.2004.030411
British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56 (Suppl 4:IV):1-64.
DOI: https://doi.org/10.1136/thx.56.suppl_4.iv1
Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA,Campbell GD. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 2001; 163:1730-54.
DOI: https://doi.org/10.1164/ajrccm.163.7.at1010
Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scandinavian Journal of Infectious Diseases 2005; 37:791-805.
DOI: https://doi.org/10.1080/00365540500264050
Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, et al.Guidelines for the management of adult lower respiratory tract infections.European Respiratory Journal 2005;26:1138-80.
DOI: https://doi.org/10.1183/09031936.05.00055705
Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279:1452–7.
DOI: https://doi.org/10.1001/jama.279.18.1452
Avdic E, Cushinotto LA, Hughes AH, et al. Impact of an
antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012; 54(11):1581–7.
DOI: https://doi.org/10.1093/cid/cis242
Ramírez JA.Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. Semin Respir Crit Care Med. 2005; 26(6):543–52.
DOI: https://doi.org/10.1055/s-2005-925521
Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164:502–8.
DOI: https://doi.org/10.1001/archinte.164.5.502
Tydeman DE. An investigation into the effectiveness of physiotherapy in the treatment of patients with community acquired pneumonia. Physio Pract 1989; 5:75–8.
DOI: https://doi.org/10.3109/09593988909044416
Chalmers JD, Taylor JK, Mandal P, et al. Validation of the Infectious Disease Society of America/America Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011; 53:503-11.
DOI: https://doi.org/10.1093/cid/cir463
PDF
FLIP
